Why The New EU Medtech Regulations Have Caused Chaos And Concern For Combination Products
Executive Summary
The EU could be on the point of serious disruption to the regulation of products that combine devices and drugs. The extent of EMA involvement is creating nervousness in the devices industry. In what direction are EU rules headed?
You may also be interested in...
Why The European Pharmaceutical Strategy Matters So Much For The Devices Sector
The regulation of medicines and medical devices have long worked along parallel, but very different, lines. Now there is increasing pressure for them to also be jointly improved to support innovation.
Moves For Go Ahead For MDR Proposal To Be Discussed At European Parliament
The European Commission’s proposal to extend transition timelines for legacy devices in the context of the Medical Device Regulation is already on the move. There are still questions, however, about whether a fast-track adoption is in the best interests of the medtech sector.
Notified Bodies Follow Expert Panel Opinions Under EU MDR To The Letter
A review of expert panel opinions related to high-risk medical devices shows no challenges yet by notified bodies to their findings.